A Policy Statement From the American Heart Association and American Stroke Association. We are going to get overwhelmed unless we prevent massive amounts of neuronal damage by stopping the neuronal cascade of death.
- Bruce Ovbiagele, MD, MSc, MAS, FAHA, Chair;
- Larry B. Goldstein, MD, FAHA;
- Randall T. Higashida, MD, FAHA;
- Virginia J. Howard, PhD, FAHA;
- S. Claiborne Johnston, MD, PhD;
- Olga A. Khavjou, MA;
- Daniel T. Lackland, DrPH, MSPH, FAHA;
- Judith H. Lichtman, PhD;
- Stephanie Mohl, BA;
- Ralph L. Sacco, MD, MSc, FAHA;
- Jeffrey L. Saver, MD, FAHA;
- Justin G. Trogdon, PhD
- on behalf of the American Heart Association Advocacy Coordinating Committee and Stroke Council
Abstract
Background and Purpose—Stroke
is a leading cause of disability, cognitive impairment, and death in
the United States and accounts for 1.7% of national
health expenditures. Because the population
is aging and the risk of stroke more than doubles for each successive
decade after
the age of 55 years, these costs are
anticipated to rise dramatically. The objective of this report was to
project future
annual costs of care for stroke from 2012 to
2030 and discuss potential cost reduction strategies.
Methods and Results—The
American Heart Association/American Stroke Association developed
methodology to project the future costs of stroke-related
care. Estimates excluded costs associated
with other cardiovascular diseases (hypertension, coronary heart
disease, and congestive
heart failure). By 2030, 3.88% of the US
population >18 years of age is projected to have had a stroke.
Between 2012 and 2030,
real (2010$) total direct annual
stroke-related medical costs are expected to increase from $71.55
billion to $183.13 billion.
Real indirect annual costs (attributable to
lost productivity) are projected to rise from $33.65 billion to $56.54
billion
over the same period. Overall, total annual
costs of stroke are projected to increase to $240.67 billion by 2030, an
increase
of 129%.
No comments:
Post a Comment